Topics

Pharmaceuticals North America NAFTA Industry Guide 20142023 [Published by Marketline] Prices from USD $795

01:06 EDT 10 Sep 2019 | BioPortfolio Reports

Pharmaceuticals North America NAFTA Industry Guide 20142023


Summary


The NAFTA Pharmaceuticals industry profile provides topline qualitative and quantitative summary information including: market share, market size value 201418, and forecast to 2023. The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Essential resource for topline data and analysis covering the NAFTA pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends and leading companies.


Key Highlights


The North American Free Trade Agreement NAFTA is a trade agreement between the countries in North America: the US, Canada and Mexico. The pharmaceuticals industry within the NAFTA countries had a total market value of $437.0 billion in 2018.The Mexico was the fastest growing country, with a CAGR of 4.6% over the 201418 period.

Within the pharmaceuticals industry, the US is the leading country among the NAFTA bloc, with market revenues of $392.8 billion in 2018. This was followed by Canada and Mexico, with a value of $23.5 and $20.7 billion, respectively.

The US is expected to lead the pharmaceuticals industry in the NAFTA bloc, with a value of $484.7 billion in 2023, followed by Canada and Mexico with expected values of $26.4 and $24.6 billion, respectively.


Scope


Save time carrying out entrylevel research by identifying the size, growth, and leading players in the NAFTA pharmaceuticals market

Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the NAFTA pharmaceuticals market

Leading company profiles reveal details of key pharmaceuticals market players' NAFTA operations and financial performance

Add weight to presentations and pitches by understanding the future growth prospects of the NAFTA pharmaceuticals market with five year forecasts

Compares data from the US, Canada and Mexico, alongside individual chapters on each country


Reasons to buy


What was the size of the NAFTA pharmaceuticals market by value in 2018?

What will be the size of the NAFTA pharmaceuticals market in 2023?

What factors are affecting the strength of competition in the NAFTA pharmaceuticals market?

How has the market performed over the last five years?

Who are the top competitors in the NAFTA pharmaceuticals market?

Original Article: Pharmaceuticals North America NAFTA Industry Guide 20142023 [Published by Marketline] Prices from USD $795

NEXT ARTICLE

More From BioPortfolio on "Pharmaceuticals North America NAFTA Industry Guide 20142023 [Published by Marketline] Prices from USD $795"

Quick Search

Relevant Topics

BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...